Overview
MMVD is chronic myxomatous degeneration and thickening of mitral valve connective tissue. Incomplete closure lets blood flow backward into the left atrium during each ventricular contraction. Over time, the left atrium and ventricle enlarge.
It usually progresses slowly over years, with few or no early symptoms. Regular auscultation and imaging help identify change. Advanced disease raises pulmonary venous pressure and can cause pulmonary edema, a common cardiac emergency.
Predisposed breeds
MMVD can occur in any breed, but is reported earlier and more frequently in:
- Cavalier King Charles Spaniel — a major predisposed breed, sometimes affected at a young age
- Maltese, Toy and Miniature Poodles, Yorkshire Terrier, Shih Tzu and Bichon Frise
- Chihuahua, Dachshund, Miniature Schnauzer and Pomeranian
- Other older small and medium-sized dogs
Large dogs can also be affected, though less frequently; DCM needs to be distinguished.
What signs should I watch for?
Early MMVD may cause only a murmur. With progression, signs can include:
- A dry, hacking cough at night or early morning, especially when lying down
- Repeated increases above the usual sleeping respiratory rate
- Slow recovery and prolonged panting after gentle walks or stairs
- Brief loss of consciousness or unsteadiness when excited (syncope)
- Pale or bluish tongue or gums
- Reduced appetite, weight loss and low energy
Is every cough caused by the heart?
Small dogs commonly cough from tracheal collapse, chronic bronchitis or lung disease. Cardiac and airway problems may coexist. Auscultation, radiographs and ultrasound together help establish the cause.
Diagnostic steps
Diagnosis combines information gathered in stages rather than one test alone.
-
Auscultation
Assess the intensity and location of a left-sided systolic murmur. The Levine grade, from 1 to 6, is a starting point for staging.
-
Chest X-rays
Assess vertebral heart score (VHS), left atrial and ventricular enlargement, pulmonary venous congestion and edema.
-
Echocardiography
Assess valve shape and thickness, quantify regurgitation with Doppler and measure chamber size for ACVIM staging. Echocardiography is the central diagnostic test.
-
Blood tests + NT-proBNP
Kidney and liver function and electrolytes establish a medication baseline. NT-proBNP supports heart failure risk assessment.
-
Blood pressure measurement
Noninvasive measurement checks for high or low pressure and helps guide medication choice and dose adjustment.
ACVIM staging
ACVIM classifies MMVD into five stages. The stage determines whether treatment should begin and which medications are appropriate.
| Stage | Condition | When to consider treatment |
|---|---|---|
| A | Predisposed breed without structural heart changes | No medication needed; regular auscultation and examinations recommended |
| B1 | Murmur present without clear heart enlargement | Medication not needed; imaging follow-up every 6–12 months |
| B2 | No heart failure symptoms, but left atrial and ventricular enlargement. ACVIM B2 criteria include murmur ≥3/6, LA/Ao ≥1.6, LVIDDN ≥1.7 and breed-adjusted VHS >10.5. Ideally, all four are met and interpreted with individual clinical findings | Pimobendan recommended to delay onset of congestive heart failure |
| C | Current or previous heart failure signs, including pulmonary edema or breathing difficulty | Combination therapy, including diuretics, inotropes and vasodilators |
| D | Refractory heart failure with reduced response to standard treatment | Dose adjustments, additional medications and intensive monitoring |
This owner-oriented table summarizes general ACVIM recommendations. The veterinarian applies them to the individual patient.
Treatment and care by stage
The central principle is treatment matched to stage. Starting too early or too late can affect outcomes. We consider both ACVIM stage and the owner's circumstances.
Medication combinations by stage
Pimobendan is recommended for asymptomatic patients meeting B2 criteria to delay congestive heart failure. Diuretics become central at stage C with current or previous congestion such as pulmonary edema. Other medication depends on stage and individual status. Kidney function, electrolytes and blood pressure are monitored.
Home monitoring — Resting respiratory rate (SRR)
Count breaths for one minute while your pet sleeps and compare with the usual rate. Contact the veterinarian if faster breathing recurs and agree on individual contact thresholds. For labored or open-mouth breathing, go straight to the nearest 24-hour emergency veterinary hospital regardless of the count.
Diet and daily care
Sodium restriction depends on stage. Maintain comfortable daily activity and adjust walks in hot or humid weather. Consistent medication times help reduce variation in effect.
Complications and concurrent conditions
Long-term treatment requires monitoring kidney and liver function and electrolytes. Tracheal collapse, chronic kidney disease and endocrine conditions can affect cardiac medication choices and are assessed together.
Frequently asked questions
Should medication start as soon as a murmur is heard?
Can MMVD be cured?
How do I measure SRR?
Will medication be lifelong?
At what age should a predisposed breed be checked?
What if symptoms suddenly worsen?
References
These external resources explain staging and stage-based management. They do not define our services or an individual prescription.